State of Wyoming’s AstraZeneca AZN Stock Holding History

State of Wyoming’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.2K	Buy	+370	New	+$69.6K	0.01%	1581
2022 Q4	–	Sell	-1	Closed	–	–	1578
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1546
2022 Q2	$0	Sell	1 -37	-97%	-$4.86K	﹤0.01%	1867
2022 Q1	$5K	Sell	38 -214	-85%	-$25.7K	﹤0.01%	1656
2021 Q4	$29K	Buy	252 +251	+25,100%	+$29.5K	0.01%	1354
2021 Q3	$0	Buy	+1	New	+$116	﹤0.01%	1222

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State of Wyoming's AZN Position: Q2 2026 in Review

State of Wyoming opened a new position in AstraZeneca (AZN) in Q2 2026: 370 shares worth $70.2K. The stake represents 0.01% of the portfolio and ranks #1581 among its holdings. This is a return to the name: State of Wyoming previously reported a position in AZN as recently as Q3 2022.

State of Wyoming first reported a position in AZN in Q3 2021 and has held it in 6 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

State of Wyoming held 370 shares of AstraZeneca worth $70.2K as of Q2 2026.
AstraZeneca was a new State of Wyoming position in Q2 2026.
AstraZeneca made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1581 holding.
State of Wyoming first reported a position in AstraZeneca in Q3 2021 and has held it in 6 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.